Transcriptional Spatial Profiling of Cancer Tissues in the Era of Immunotherapy: The Potential and Promise
Intratumoral heterogeneity poses a major challenge to making an accurate diagnosis and establishing personalized treatment strategies for cancer patients. Moreover, this heterogeneity might underlie treatment resistance, disease progression, and cancer relapse. For example, while immunotherapies can...
Main Authors: | Sanjna Nilesh Nerurkar, Denise Goh, Chun Chau Lawrence Cheung, Pei Qi Yvonne Nga, Jeffrey Chun Tatt Lim, Joe Poh Sheng Yeong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2572 |
Similar Items
-
Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity
by: Mai Chan Lau, et al.
Published: (2022-09-01) -
Clonal Evolution and Timing of Metastatic Colorectal Cancer
by: Sarah Siraj, et al.
Published: (2020-10-01) -
The Impact of Clonal Hierarchy and Heterogeneity on Phenotypic Manifestations of Myelodysplastic Neoplasms
by: Siba El Hussein, et al.
Published: (2022-11-01) -
Invasive clonal plants possess greater capacity for division of labor than natives in high patch contrast environments
by: Jin Zhang, et al.
Published: (2023-07-01) -
Measuring Intratumoral Heterogeneity of Immune Repertoires
by: Diana Vladimirovna Yuzhakova, et al.
Published: (2020-05-01)